You are here

Article info

Article menu

Download PDFPDF

Original Article
Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related macular degeneration. The BEAT-AMD-Study
Free

Authors

  1. Dr K E Schmid-Kubista, Department of Ophthalmology, Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery, Rudolf Foundation Clinic, Juchgasse 25, 1030 Vienna, Austria; katharina.schmid-kubista{at}wienkav.at
View Full Text

Citation

Schmid-Kubista KE, Krebs I, Gruenberger B, et al
Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related macular degeneration. The BEAT-AMD-Study
British Journal of Ophthalmology 2009;93:914-919.

Publication history

  • Accepted February 9, 2009
  • First published April 29, 2009.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2009 BMJ Publishing Group Ltd